Fundz

Recode Therapeutics, Inc. reported raising $40 Million in an initial SEC Form D filing, from an offering of $80 Million

PRIVATEOct 25, 2021$40M of $80M raised

Amount Raised

$40 Million

$40 Million sold, per SEC Form D (first sale Oct 25, 2021)

Round Type

Venture

Menlo ParkBiotechnologyHealthcareHealth Care

Quick answer

ReCode Therapeutics raised $40 Million in a funding round, dated October 25, 2021. ReCode Therapeutics is based in Menlo Park, California, United States.

How much did ReCode Therapeutics raise?
ReCode Therapeutics raised $40 Million in a funding round on October 25, 2021.
What does ReCode Therapeutics do?
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
Where is ReCode Therapeutics based and how big is it?
ReCode Therapeutics is based in Menlo Park, California, United States.
Who are the decision-makers at ReCode Therapeutics?
Fundz holds 1 contact at ReCode Therapeutics, including the Head of Clinical Operations | Rare Diseases. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as ReCode Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • iSpecimen raised $21M on December 9, 2021.
  • PetDx, Inc. raised $62M (Series B) on December 9, 2021.
  • AEON Biopharma raised $30M on December 8, 2021.
  • Pasithea Therapeutics Corp. raised $30M on December 7, 2021.
  • Petros Pharmaceuticals, Inc. raised $3.5M (Seed) on December 3, 2021.
  • CytoDyn raised $11M on December 3, 2021.

Who to call at ReCode Therapeutics, and when

A new round usually means ReCode Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ReCode Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ReCode Therapeutics

Location

Menlo Park, California, United States

About

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ReCode Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPriya, Head of Clinical Operations | Rare Dise… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ReCode Therapeutics's next move

See what Strategic adds

ReCode Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.